← Back
Data updated: Sep 20, 2026
STRATA MEDICAL INNOVATIONS
Pharma Pharmaceuticals
STRATA MEDICAL INNOVATIONS is a pharmaceutical company with 1 FDA-approved products.
2014
Since
1
Drugs
-
Trials
1
New Drugs (2yr)
Modality:
1 Small Molecules
STRATA MEDICAL INNOVATIONS's Key Drugs
STRATA MEDICAL INNOVATIONS's core commercial portfolio centers on NITROUS OXIDE, USP — its most strategically important drugs approved in the last 15 years.
STRATA MEDICAL INNOVATIONS's Recent FDA Approvals
STRATA MEDICAL INNOVATIONS secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
STRATA MEDICAL INNOVATIONS's Therapeutic Areas
Disease areas where STRATA MEDICAL INNOVATIONS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
STRATA MEDICAL INNOVATIONS Pipeline Snapshot
Active clinical trials for STRATA MEDICAL INNOVATIONS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • NITROUS OXIDE, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2014-11-25
- Latest
- 2014-11-25
- Applications
- 1